Drug information for ROSIGLITAZONE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
2MG
Tentative Approval
ROSIGLITAZONE MALEATE
rosiglitazone
DR REDDYS LABS INC
76748
TABLET; ORAL
4MG
Tentative Approval
ROSIGLITAZONE MALEATE
rosiglitazone
DR REDDYS LABS INC
"
TABLET; ORAL
8MG
Tentative Approval
ROSIGLITAZONE MALEATE
rosiglitazone
DR REDDYS LABS INC
"
TABLET; ORAL
2MG
Tentative Approval
ROSIGLITAZONE MALEATE
rosiglitazone
WATSON LABS
78023
TABLET; ORAL
4MG
Tentative Approval
ROSIGLITAZONE MALEATE
rosiglitazone
WATSON LABS
"
TABLET; ORAL
8MG
Tentative Approval
ROSIGLITAZONE MALEATE
rosiglitazone
WATSON LABS
"
Drug Adverse Effects information for ROSIGLITAZONE
Role code
Indications
Reaction
# Reports
PS
DIABETES MELLITUS
ANAEMIA
2
PS
DIABETES MELLITUS
ATRIAL FIBRILLATION
1
PS
DIABETES MELLITUS
CARDIAC DISORDER
1
PS
DIABETES MELLITUS
CARDIAC FAILURE CONGESTIVE
2
PS
DIABETES MELLITUS
CARDIOVASCULAR DISORDER
1
PS
DIABETES MELLITUS
CEREBROVASCULAR ACCIDENT
1
PS
DIABETES MELLITUS
CORONARY ARTERY DISEASE
1
PS
DIABETES MELLITUS
DYSPNOEA
1
PS
DIABETES MELLITUS
FEMUR FRACTURE
1
PS
DIABETES MELLITUS
HYPERHIDROSIS
1
PS
DIABETES MELLITUS
HYPERTENSION
1
PS
DIABETES MELLITUS
LUNG DISORDER
1
PS
DIABETES MELLITUS
MYOCARDIAL INFARCTION
1
PS
DIABETES MELLITUS
OEDEMA
1
PS
DIABETES MELLITUS
OEDEMA PERIPHERAL
1
PS
DIABETES MELLITUS
OSTEOPOROSIS
1
PS
DIABETES MELLITUS
PALLOR
1
PS
DIABETES MELLITUS
THROMBOSIS
1
PS
TYPE 2 DIABETES MELLITUS
BUNDLE BRANCH BLOCK RIGHT
1
PS
TYPE 2 DIABETES MELLITUS
CARDIAC DISORDER
1
PS
TYPE 2 DIABETES MELLITUS
CONDITION AGGRAVATED
1
PS
TYPE 2 DIABETES MELLITUS
CORONARY ARTERY DISEASE
1
PS
TYPE 2 DIABETES MELLITUS
DEATH
1
PS
TYPE 2 DIABETES MELLITUS
LIVER DISORDER
1
PS
TYPE 2 DIABETES MELLITUS
MYOCARDIAL INFARCTION
1
PS
TYPE 2 DIABETES MELLITUS
MYOCARDIAL ISCHAEMIA
1
PS
TYPE 2 DIABETES MELLITUS
SURGERY
1
SS
ARTHRALGIA
BLOOD CREATININE INCREASED
1
SS
ARTHRALGIA
BLOOD UREA INCREASED
1
SS
ARTHRALGIA
DEHYDRATION
1
SS
ARTHRALGIA
ELECTROCARDIOGRAM ST SEGMENT ELEVATION
1
SS
ARTHRALGIA
HYPERKALAEMIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
BLADDER CANCER
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
DEEP VEIN THROMBOSIS
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
FATIGUE
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
METASTASES TO LIVER
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
METASTASES TO LUNG
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
METASTASES TO PERITONEUM
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
NEOPLASM PROGRESSION
2
SS
TYPE 2 DIABETES MELLITUS
CARDIAC FAILURE CONGESTIVE
2
SS
TYPE 2 DIABETES MELLITUS
HEART INJURY
2
SS
URINARY TRACT INFECTION
BLOOD CREATININE INCREASED
1
SS
URINARY TRACT INFECTION
BLOOD UREA INCREASED
1
SS
URINARY TRACT INFECTION
DEHYDRATION
1
SS
URINARY TRACT INFECTION
ELECTROCARDIOGRAM ST SEGMENT ELEVATION
1
SS
URINARY TRACT INFECTION
HYPERKALAEMIA
1
C
ARTHRALGIA
ASTHENIA
1
C
ARTHRALGIA
BLOOD CREATININE INCREASED
1
C
ARTHRALGIA
ELECTROCARDIOGRAM ABNORMAL
1
C
ARTHRALGIA
HYPERHIDROSIS
1
C
ARTHRALGIA
HYPERKALAEMIA
1
C
ARTHRALGIA
NAUSEA
1
C
BLOOD CORTICOTROPHIN INCREASED
ANOSMIA
2
C
BLOOD CORTICOTROPHIN INCREASED
AREFLEXIA
2
C
BLOOD CORTICOTROPHIN INCREASED
ASPIRATION
2
C
BLOOD CORTICOTROPHIN INCREASED
BACK PAIN
2
C
BLOOD CORTICOTROPHIN INCREASED
BLOOD CORTICOTROPHIN INCREASED
2
C
BLOOD CORTICOTROPHIN INCREASED
CORTISOL FREE URINE INCREASED
2
C
BLOOD CORTICOTROPHIN INCREASED
CRANIAL NERVE PARALYSIS
1
C
BLOOD CORTICOTROPHIN INCREASED
CUSHING'S SYNDROME
1
C
BLOOD CORTICOTROPHIN INCREASED
DEATH
2
C
BLOOD CORTICOTROPHIN INCREASED
DYSPHAGIA
3
C
BLOOD CORTICOTROPHIN INCREASED
EYE MOVEMENT DISORDER
2
C
BLOOD CORTICOTROPHIN INCREASED
FATIGUE
2
C
BLOOD CORTICOTROPHIN INCREASED
HEADACHE
2
C
BLOOD CORTICOTROPHIN INCREASED
HEMIANOPIA
2
C
BLOOD CORTICOTROPHIN INCREASED
HYPERGLYCAEMIA
3
C
BLOOD CORTICOTROPHIN INCREASED
HYPERTENSION
1
C
BLOOD CORTICOTROPHIN INCREASED
HYPOAESTHESIA
2
C
BLOOD CORTICOTROPHIN INCREASED
MEMORY IMPAIRMENT
2
C
BLOOD CORTICOTROPHIN INCREASED
METASTASES TO BONE
3
C
BLOOD CORTICOTROPHIN INCREASED
METASTASES TO SPINE
1
C
BLOOD CORTICOTROPHIN INCREASED
MUSCULAR WEAKNESS
2
C
BLOOD CORTICOTROPHIN INCREASED
NEOPLASM PROGRESSION
2
C
BLOOD CORTICOTROPHIN INCREASED
NEUROENDOCRINE TUMOUR
1
C
BLOOD CORTICOTROPHIN INCREASED
PITUITARY TUMOUR
1
C
BLOOD CORTICOTROPHIN INCREASED
POST PROCEDURAL COMPLICATION
1
C
BLOOD CORTICOTROPHIN INCREASED
PUPILLARY REFLEX IMPAIRED
2
C
BLOOD CORTICOTROPHIN INCREASED
SECONDARY HYPOGONADISM
1
C
BLOOD CORTICOTROPHIN INCREASED
SKIN HYPERPIGMENTATION
2
C
BLOOD CORTICOTROPHIN INCREASED
SMALL CELL CARCINOMA
1
C
HYPERTENSION
COLONIC POLYP
1
C
HYPERTENSION
DIABETES MELLITUS
1
C
HYPERTENSION
DIVERTICULUM INTESTINAL
1
C
HYPERTENSION
GAIT DISTURBANCE
1
C
HYPERTENSION
THYROID CANCER
1
C
HYPERTENSION
THYROID NEOPLASM
1
C
HYPERTENSION
VERTIGO
1
C
MULTIPLE SCLEROSIS
COLONIC POLYP
1
C
MULTIPLE SCLEROSIS
DIABETES MELLITUS
1
C
MULTIPLE SCLEROSIS
DIVERTICULUM INTESTINAL
1
C
MULTIPLE SCLEROSIS
GAIT DISTURBANCE
1
C
MULTIPLE SCLEROSIS
THYROID CANCER
1
C
MULTIPLE SCLEROSIS
THYROID NEOPLASM
1
C
MULTIPLE SCLEROSIS
VERTIGO
1
C
PRODUCT USED FOR UNKNOWN INDICATION
CRANIAL NERVE PARALYSIS
2
C
PRODUCT USED FOR UNKNOWN INDICATION
CUSHING'S SYNDROME
2
C
PRODUCT USED FOR UNKNOWN INDICATION
DYSPHAGIA
2
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERGLYCAEMIA
2
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERTENSION
2
C
PRODUCT USED FOR UNKNOWN INDICATION
METASTASES TO BONE
2
C
PRODUCT USED FOR UNKNOWN INDICATION
METASTASES TO SPINE
2
C
PRODUCT USED FOR UNKNOWN INDICATION
NEUROENDOCRINE TUMOUR
2
C
PRODUCT USED FOR UNKNOWN INDICATION
PITUITARY TUMOUR
2
C
PRODUCT USED FOR UNKNOWN INDICATION
POST PROCEDURAL COMPLICATION
2
C
PRODUCT USED FOR UNKNOWN INDICATION
SECONDARY HYPOGONADISM
2
C
PRODUCT USED FOR UNKNOWN INDICATION
SMALL CELL CARCINOMA
2
C
SMALL CELL CARCINOMA
ANOSMIA
4
C
SMALL CELL CARCINOMA
AREFLEXIA
4
C
SMALL CELL CARCINOMA
ASPIRATION
4
C
SMALL CELL CARCINOMA
BACK PAIN
4
C
SMALL CELL CARCINOMA
BLOOD CORTICOTROPHIN INCREASED
4
C
SMALL CELL CARCINOMA
CORTISOL FREE URINE INCREASED
4
C
SMALL CELL CARCINOMA
DEATH
4
C
SMALL CELL CARCINOMA
DYSPHAGIA
4
C
SMALL CELL CARCINOMA
EYE MOVEMENT DISORDER
4
C
SMALL CELL CARCINOMA
FATIGUE
4
C
SMALL CELL CARCINOMA
HEADACHE
4
C
SMALL CELL CARCINOMA
HEMIANOPIA
4
C
SMALL CELL CARCINOMA
HYPERGLYCAEMIA
4
C
SMALL CELL CARCINOMA
HYPOAESTHESIA
4
C
SMALL CELL CARCINOMA
MEMORY IMPAIRMENT
4
C
SMALL CELL CARCINOMA
METASTASES TO BONE
4
C
SMALL CELL CARCINOMA
MUSCULAR WEAKNESS
4
C
SMALL CELL CARCINOMA
NEOPLASM PROGRESSION
4
C
SMALL CELL CARCINOMA
PUPILLARY REFLEX IMPAIRED
4
C
SMALL CELL CARCINOMA
SKIN HYPERPIGMENTATION
4
C
TYPE 2 DIABETES MELLITUS
COLONIC POLYP
1
C
TYPE 2 DIABETES MELLITUS
DIABETES MELLITUS
1
C
TYPE 2 DIABETES MELLITUS
DIVERTICULUM INTESTINAL
1
C
TYPE 2 DIABETES MELLITUS
GAIT DISTURBANCE
1
C
TYPE 2 DIABETES MELLITUS
THYROID CANCER
1
C
TYPE 2 DIABETES MELLITUS
THYROID NEOPLASM
1
C
TYPE 2 DIABETES MELLITUS
VERTIGO
1
C
URINARY TRACT INFECTION
ASTHENIA
1
C
URINARY TRACT INFECTION
BLOOD CREATININE INCREASED
1
C
URINARY TRACT INFECTION
ELECTROCARDIOGRAM ABNORMAL
1
C
URINARY TRACT INFECTION
HYPERHIDROSIS
1
C
URINARY TRACT INFECTION
HYPERKALAEMIA
1
C
URINARY TRACT INFECTION
NAUSEA
1
Ads by Google